NO20073574L - Triazolsubstituerte aminobenzofenonforbindelser - Google Patents
Triazolsubstituerte aminobenzofenonforbindelserInfo
- Publication number
- NO20073574L NO20073574L NO20073574A NO20073574A NO20073574L NO 20073574 L NO20073574 L NO 20073574L NO 20073574 A NO20073574 A NO 20073574A NO 20073574 A NO20073574 A NO 20073574A NO 20073574 L NO20073574 L NO 20073574L
- Authority
- NO
- Norway
- Prior art keywords
- triazole
- aminobenzophenone compounds
- compounds
- substituted aminobenzophenone
- substituted
- Prior art date
Links
- -1 Triazole-substituted aminobenzophenone compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63500004P | 2004-12-13 | 2004-12-13 | |
| DKPA200401942 | 2004-12-16 | ||
| PCT/DK2005/000757 WO2006063585A1 (en) | 2004-12-13 | 2005-11-28 | Triazole substituted aminobenzophenone compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073574L true NO20073574L (no) | 2007-07-10 |
Family
ID=37715934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073574A NO20073574L (no) | 2004-12-13 | 2007-07-10 | Triazolsubstituerte aminobenzofenonforbindelser |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8293772B2 (pl) |
| EP (1) | EP1828148B1 (pl) |
| JP (1) | JP5015005B2 (pl) |
| KR (1) | KR101260236B1 (pl) |
| CN (1) | CN101115728B (pl) |
| AR (1) | AR051792A1 (pl) |
| AT (1) | ATE455768T1 (pl) |
| AU (1) | AU2005316034B2 (pl) |
| BR (1) | BRPI0518993A2 (pl) |
| CA (1) | CA2590479A1 (pl) |
| DE (1) | DE602005019093D1 (pl) |
| DK (1) | DK1828148T3 (pl) |
| ES (1) | ES2341473T3 (pl) |
| HR (1) | HRP20100225T1 (pl) |
| IL (1) | IL183513A0 (pl) |
| MX (1) | MX2007006739A (pl) |
| NO (1) | NO20073574L (pl) |
| PL (1) | PL1828148T3 (pl) |
| PT (1) | PT1828148E (pl) |
| RU (1) | RU2394818C2 (pl) |
| UA (1) | UA90698C2 (pl) |
| WO (1) | WO2006063585A1 (pl) |
| ZA (1) | ZA200704809B (pl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE469135T1 (de) * | 2002-05-30 | 2010-06-15 | Scripps Research Inst | Kupferkatalysierte ligierung von aziden und acetylenen |
| WO2007148074A1 (en) * | 2006-06-21 | 2007-12-27 | Hammersmith Imanet Limited | Chemical methods and apparatus |
| US8080540B2 (en) | 2006-09-19 | 2011-12-20 | Abbott Products Gmbh | Therapeutically active triazoles and their use |
| KR100932093B1 (ko) | 2006-09-27 | 2009-12-16 | 주식회사종근당 | 미세소관 형성 저해제로서 유용한 벤조페논 유도체 |
| US8288367B2 (en) | 2006-11-30 | 2012-10-16 | Solvay Pharmaceuticals Gmbh | Substituted estratriene derivatives as 17BETA HSD inhibitors |
| SI2225231T1 (sl) * | 2007-12-18 | 2011-12-30 | Actelion Pharmaceuticals Ltd | Derivati aminotriazola kot alx agonisti |
| EP2272845B1 (en) * | 2008-03-26 | 2015-03-04 | Chong Kun Dang Pharmaceutical Corp. | Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same |
| US9029408B2 (en) | 2008-06-16 | 2015-05-12 | Gtx, Inc. | Compounds for treatment of cancer |
| US8822513B2 (en) | 2010-03-01 | 2014-09-02 | Gtx, Inc. | Compounds for treatment of cancer |
| US9447049B2 (en) | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
| HUE060249T2 (hu) | 2008-06-16 | 2023-02-28 | Univ Tennessee Res Found | Vegyületek rák kezelésére |
| JP5873439B2 (ja) | 2009-12-22 | 2016-03-01 | レオ ファーマ アクティーゼルスカブ | ビタミンｄ類似体および溶媒と界面活性剤の混合物を含む皮膚組成物 |
| WO2011076208A2 (en) | 2009-12-22 | 2011-06-30 | Leo Pharma A/S | Calcipotriol monohydrate nanocrystals |
| US20130023501A1 (en) | 2009-12-22 | 2013-01-24 | Leo Pharma A/S | Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue |
| US8912184B1 (en) | 2010-03-01 | 2014-12-16 | Alzheimer's Institute Of America, Inc. | Therapeutic and diagnostic methods |
| AU2010347233B2 (en) | 2010-03-01 | 2015-06-18 | Oncternal Therapeutics, Inc. | Compounds for treatment of cancer |
| KR101666759B1 (ko) * | 2015-08-06 | 2016-10-18 | 경북대학교 산학협력단 | 1-벤조피란메틸-1h-1,2,3-트리아졸 유도체 및 이의 용도 |
| CN106632285B (zh) * | 2016-11-23 | 2019-11-01 | 河南师范大学 | 一种齐多夫定-1,2,3-三氮唑类化合物的合成方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1709907A3 (ru) * | 1988-01-07 | 1992-01-30 | Е.И.Дюпон Де Немур Энд Компани (Фирма) | Способ получени азолов |
| GB9701453D0 (en) * | 1997-01-24 | 1997-03-12 | Leo Pharm Prod Ltd | Aminobenzophenones |
| DK1202954T3 (da) | 1999-07-16 | 2004-02-09 | Leo Pharma As | Nye aminobenzophenoner |
| PT1202957E (pt) | 1999-07-16 | 2005-01-31 | Leo Pharma As | Aminobenzofenonas como inibidoras de il-1beta e tnf-alpha |
| PL352944A1 (pl) | 1999-07-16 | 2003-09-22 | Leo Pharma | Aminobenzofenony jako inhibitory IL-1beta i TNF-alfa |
| RU2247719C2 (ru) | 1999-07-16 | 2005-03-10 | Лео Фармасьютикал Продактс Лтд.А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) | Аминобензофеноны как ингибиторы il-1 бета и tnf-альфа, фармацевтическая композиция и способ лечения и/или профилактики воспалительных заболеваний |
| NZ516825A (en) | 1999-07-16 | 2004-05-28 | Leo Pharm Prod Ltd | Aminobenzophenones as inhibitors of IL-1beta and TNF-alpha |
| HUP0203813A3 (en) | 1999-12-06 | 2008-03-28 | Leo Pharma As | Aminobenzophenones as inhibitors of il-1betha and tnf-alpha, pharmaceutical compositions containing them and their use |
| RU2270194C2 (ru) | 2000-05-22 | 2006-02-20 | Лео Фарма А/С | Бензофеноны как ингибиторы il-1бета и tnf-альфа, фармацевтическая композиция и способ лечения |
| GB0107368D0 (en) | 2001-03-23 | 2001-05-16 | Novartis Ag | Organic compounds |
| AU2002338286A1 (en) | 2001-04-10 | 2002-10-28 | Leo Pharma A/S | Novel aminophenyl ketone derivatives |
| KR100896667B1 (ko) | 2001-08-28 | 2009-05-14 | 레오 파마 에이/에스 | 신규한 아미노벤조페논 및 이를 포함하는 약제학적 조성물 |
| PL377377A1 (pl) | 2002-12-20 | 2006-02-06 | Leo Pharma A/S | Nowe związki aminobenzofenonu |
| ZA200510137B (en) * | 2003-07-24 | 2007-04-25 | Leo Pharma As | Novel aminobenzophenone compounds |
| US20090313239A1 (en) | 2008-06-16 | 2009-12-17 | Microsoft Corporation | Adaptive Visual Similarity for Text-Based Image Search Results Re-ranking |
-
2005
- 2005-11-28 JP JP2007545836A patent/JP5015005B2/ja not_active Expired - Fee Related
- 2005-11-28 UA UAA200707890A patent/UA90698C2/ru unknown
- 2005-11-28 ES ES05804019T patent/ES2341473T3/es not_active Expired - Lifetime
- 2005-11-28 RU RU2007126648/04A patent/RU2394818C2/ru not_active IP Right Cessation
- 2005-11-28 HR HR20100225T patent/HRP20100225T1/hr unknown
- 2005-11-28 AU AU2005316034A patent/AU2005316034B2/en not_active Ceased
- 2005-11-28 DE DE602005019093T patent/DE602005019093D1/de not_active Expired - Lifetime
- 2005-11-28 CN CN2005800480385A patent/CN101115728B/zh not_active Expired - Fee Related
- 2005-11-28 MX MX2007006739A patent/MX2007006739A/es active IP Right Grant
- 2005-11-28 EP EP05804019A patent/EP1828148B1/en not_active Expired - Lifetime
- 2005-11-28 PL PL05804019T patent/PL1828148T3/pl unknown
- 2005-11-28 BR BRPI0518993-4A patent/BRPI0518993A2/pt not_active IP Right Cessation
- 2005-11-28 AT AT05804019T patent/ATE455768T1/de active
- 2005-11-28 CA CA002590479A patent/CA2590479A1/en not_active Abandoned
- 2005-11-28 ZA ZA200704809A patent/ZA200704809B/xx unknown
- 2005-11-28 KR KR1020077015959A patent/KR101260236B1/ko not_active Expired - Fee Related
- 2005-11-28 PT PT05804019T patent/PT1828148E/pt unknown
- 2005-11-28 DK DK05804019.7T patent/DK1828148T3/da active
- 2005-11-28 WO PCT/DK2005/000757 patent/WO2006063585A1/en not_active Ceased
- 2005-12-02 US US11/292,064 patent/US8293772B2/en not_active Expired - Fee Related
- 2005-12-12 AR ARP050105193A patent/AR051792A1/es not_active Application Discontinuation
-
2007
- 2007-05-29 IL IL183513A patent/IL183513A0/en unknown
- 2007-07-10 NO NO20073574A patent/NO20073574L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1828148A1 (en) | 2007-09-05 |
| JP2008523115A (ja) | 2008-07-03 |
| CN101115728B (zh) | 2012-12-19 |
| ATE455768T1 (de) | 2010-02-15 |
| DE602005019093D1 (de) | 2010-03-11 |
| UA90698C2 (en) | 2010-05-25 |
| ES2341473T3 (es) | 2010-06-21 |
| MX2007006739A (es) | 2007-08-02 |
| WO2006063585A1 (en) | 2006-06-22 |
| BRPI0518993A2 (pt) | 2008-12-23 |
| KR20070095945A (ko) | 2007-10-01 |
| RU2394818C2 (ru) | 2010-07-20 |
| PT1828148E (pt) | 2010-05-04 |
| HRP20100225T1 (hr) | 2010-07-31 |
| AU2005316034A1 (en) | 2006-06-22 |
| US20060128766A1 (en) | 2006-06-15 |
| JP5015005B2 (ja) | 2012-08-29 |
| DK1828148T3 (da) | 2010-05-17 |
| CN101115728A (zh) | 2008-01-30 |
| RU2007126648A (ru) | 2009-01-20 |
| AR051792A1 (es) | 2007-02-07 |
| AU2005316034B2 (en) | 2012-01-19 |
| PL1828148T3 (pl) | 2010-08-31 |
| KR101260236B1 (ko) | 2013-05-06 |
| IL183513A0 (en) | 2007-09-20 |
| ZA200704809B (en) | 2008-08-27 |
| EP1828148B1 (en) | 2010-01-20 |
| US8293772B2 (en) | 2012-10-23 |
| CA2590479A1 (en) | 2006-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20073574L (no) | Triazolsubstituerte aminobenzofenonforbindelser | |
| NO20060230L (no) | Nye aminobenzofenonforbindelser | |
| NO20082594L (no) | Pyrimidinylbenzotiofenforbindelser | |
| ATE448232T1 (de) | Substituierte heterozyklen | |
| NO20092639L (no) | 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav | |
| NO20055516L (no) | Kannabinoidreceptorligander og anvendelser derav | |
| CY1116754T1 (el) | Παραγωγα νιτροκατεχολης ως αναστολεις της comt | |
| TW200714590A (en) | Heterocyclic inhibitors of MEK and methods of use thereof | |
| EA200802213A1 (ru) | Способы лечения заболеваний крови | |
| EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
| CY1106476T1 (el) | Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες | |
| NO20055731L (no) | Cannabinoide reseptorligander og deres anvendelse | |
| NO20053792L (no) | Heterocykly-3-sulfonylindazoler som 5-hydroksytryptamin-6 ligander | |
| NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
| NO20055741L (no) | Nye kjemiske forbindelser | |
| ECSP066986A (es) | Beta-carbolinas utiles para tratar enfermedades inflamatorias | |
| ECSP055844A (es) | Nuevos compuestos triciclicos | |
| NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
| SE0300457D0 (sv) | Novel compounds | |
| DE502005005652D1 (de) | Heterocyclyl-substituierte nonadepsipeptide | |
| ATE455789T1 (de) | Substituierte nonadepsipeptide | |
| ATE496047T1 (de) | Phenylen-bis-oxazolidin-derivate und ihre verwendung als antikoagulantien | |
| WO2005080549A3 (de) | Trioxacarcine und deren verwendung gegen infektionskrankheiten | |
| NO20053562L (no) | Nye aminobenzofenonforbindelser | |
| ATE553088T1 (de) | Substituierte chinolone ii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Reestablishment of rights (par. 72 patents act) | ||
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |